AI assistant
GENETIC TECHNOLOGIES LIMITED — Capital/Financing Update 2008
Dec 21, 2008
65022_rns_2008-12-21_a69b4d68-c823-4f92-a8fb-34159ba8bc0a.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [558 x 65] intentionally omitted <==
==> picture [558 x 66] intentionally omitted <==
ASX ANNOUNCEMENT December 22[nd] , 2008
GTG Grants License to TIB MOLBIOL
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to advise that its newly-elected Board of Directors has reaffirmed the importance of expanding the global GTG licensing programme, in order to make its patented inventions widely available and to generate significant additional revenues for the Company.
Consistent with this clarification, GTG is pleased to announce it has now granted a license to its noncoding patents to TIB MOLBIOL Syntheselabor GmbH, of Berlin, Germany. TIB MOLBIOL produces and sells various reagent kits and components for advanced genetic testing. While the precise terms of the commercial license granted to TIB MOLBIOL are covered by standard confidentiality provisions, GTG can confirm that this license has now been signed and that the full consideration payable to GTG under the formal “Settlement and License Agreement” has now been received by the Company.
This is the 39[th] commercial license to the non-coding patents granted by GTG, and the 5[th] such license to be granted to parties located in Europe. Other similar opportunities are now being actively pursued worldwide by GTG personnel.
FOR INFORMATION REGARDING THIS ANNOUNCEMENT PLEASE CONTACT
Thomas G. Howitt Company Secretary
Genetic Technologies Limited (ABN 17 009 212 328) Phone: +61 3 8412 7000
Genetic Technologies Limited • Website : www.gtg.com.au • Email : [email protected] ABN 17 009 212 328 Registered Office • 60-66 Hanover Street Fitzroy Victoria 3065 Australia • Postal Address P.O. Box 115 Fitzroy Victoria 3065 Australia Phone +61 3 8412 7000 • Fax +61 3 8412 7040